CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes K Rawat, A Tewari, X Li, AB Mara, WT King, SL Gibbings, CF Nnam, ... Journal of Experimental Medicine 220 (6), e20222129, 2023 | 53 | 2023 |
Dithiocarbamate–thiourea hybrids useful as vaginal microbicides also show reverse transcriptase inhibition: Design, synthesis, docking and pharmacokinetic studies V Bala, S Jangir, D Mandalapu, S Gupta, YS Chhonker, N Lal, ... Bioorganic & Medicinal Chemistry Letters 25 (4), 881-886, 2015 | 37 | 2015 |
Redefining innate natural antibodies as important contributors to anti-tumor immunity K Rawat, A Tewari, MJ Morrisson, TD Wager, CV Jakubzick Elife 10, e69713, 2021 | 21 | 2021 |
Identification of MΦ specific POTEE expression: Its role in mTORC2 activation via protein-protein interaction in TAMs U Vekariya, K Rawat, R Saxena, RK Tripathi Cellular Immunology 335, 30-40, 2019 | 20 | 2019 |
Coordinated chemokine expression defines macrophage subsets across tissues X Li, AB Mara, SC Musial, FW Kolling, SL Gibbings, N Gerebtsov, ... Nature immunology 25 (6), 1110-1122, 2024 | 17 | 2024 |
N-Alkyl/aryl-4-(3-substituted-3-phenylpropyl) piperazine-1-carbothioamide as dual-action vaginal microbicides with reverse transcriptase inhibition V Bala, D Mandalapu, S Gupta, S Jangir, B Kushwaha, YS Chhonker, ... European Journal of Medicinal Chemistry 101, 640-650, 2015 | 14 | 2015 |
Natural antibodies alert the adaptive immune system of the presence of transformed cells in early tumorigenesis K Rawat, SM Soucy, FW Kolling, KM Diaz, WT King, A Tewari, ... The Journal of Immunology 209 (7), 1252-1259, 2022 | 11 | 2022 |
HIV-1 Nef-POTEE; a novel interaction modulates macrophage dissemination via mTORC2 signaling pathway U Vekariya, R Saxena, P Singh, K Rawat, B Kumar, S Kumari, ... Life sciences 214, 158-166, 2018 | 11 | 2018 |
Targeting resident macrophages in cancer X Li, K Rawat, CV Jakubzick Nature immunology 22 (9), 1078-1079, 2021 | 9 | 2021 |
HIV-1 Nef physically associate with CAMKIIδ–ASK-1 complex to inhibit p38MAPK signalling and apoptosis in infected cells P Kumar, K Rawat, T Sharma, S Kumari, R Saxena, B Kumar, T Baghel, ... Life sciences 224, 263-273, 2019 | 9 | 2019 |
LN Monocytes Limit DC-Poly I:C Induced Cytotoxic T Cell Response via IL-10 and Induction of Suppressor CD4 T Cells A Tewari, MG Prabagar, SL Gibbings, K Rawat, CV Jakubzick Frontiers in Immunology 12, 763379, 2021 | 8 | 2021 |
Synthesis, Biological Evaluation and Molecular Modeling Studies of New 2, 3‐Diheteroaryl Thiazolidin‐4‐Ones as NNRTI s U Debnath, S Verma, P Singh, K Rawat, SK Gupta, RK Tripathi, ... Chemical Biology & Drug Design 86 (5), 1285-1291, 2015 | 7 | 2015 |
Targeted depletion of BTF3a in macrophages activates autophagic pathway to eliminate Mycobacterium tuberculosis K Rawat, S Das, BSV Vinod, U Vekariya, T Garg, A Dasgupta, RK Tripathi Life sciences 220, 21-31, 2019 | 4 | 2019 |
High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance MA Saeed, B Peng, K Kim, K Rawat, LM Kuehm, ZR Siegel, A Borkowski, ... Cancer immunology research 12 (5), 559-574, 2024 | 3 | 2024 |
Natural antibodies drive type 2 immunity in response to damage-associated molecular patterns AB Mara, K Rawat, WT King, CV Jakubzick JCI insight 9 (8), e177230, 2024 | 2 | 2024 |
Channeling antigens to CD8+ T cells K Rawat, CV Jakubzick Science 330 (6651), 1218-1219, 2023 | 2 | 2023 |
A critical role for B cells in cancer immune surveillance K Rawat, A Tewari, CV Jakubzick bioRxiv, 2020.09. 19.304790, 2020 | 2 | 2020 |
Immunogenicity threshold in allogeneic cells impacts CTL response to nondominant congenic antigens K Rawat, AB Mara, WT King, CF Nnam, CV Jakubzick The Journal of Immunology 211 (11), 1623-1629, 2023 | 1 | 2023 |
391 Dose specific immune profile alterations of sipuleucel-T with potential clinical relevance in metastatic castrate-resistant prostate cancer MA Saeed, K Rawat, K Kim, R Pachynski Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
903 A novel role of chemerin in the suppression of macrophage polarization into M2-like phenotype ZR Siegel, MA Saeed, E Arvanitis, K Kim, K Rawat, R Pachynski Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |